Newsbenzinga
HC Wainwright & Co. Maintains Buy on Atrium Therapeutics, Lowers Price Target to $20
· Published
Article summary
Please check the source for details.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…